Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Desjardins selling hard

<< Previous

Bullboard Posts

Next >>

Comment by mmayeron Jun 27, 2018 11:38am

54 Views

Post# 28236953

RE:RE:RE:RE:RE:Desjardins selling hard

OMG!
If you are going to call out people as being stupid, don't be more stupid than them!!!

https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00024061

See the form of proxy dated June 5th. If you are even capable to understand how to get there...

If not, I can help out. The document is for (and I quote) "Form of Proxy - Annual General Meeting to be held on June 27, 2018"

Now crawl back into your hole!

H0WITZER wrote:

unclepieman wrote: How is this a meeting? you are confused

Nothing in that article mentioned anything about a meeting unless I'm blind. I swear most of the people on this board have next to no f***** brain. You can't trust them to run a bath let alone money/stocks.